The prevalence of anemia was almost twice in patients with baseline CD4+ cell count ≤200 cells/mm3 as compared to patients with CD4+ cell count >200 cells/mm3 (64.0% versus 36.4%) in which 6.8% of patients with low CD4+ cell count tend to develop severe anemia. This evidence concerns the gene CD4 and anemia (phenotype).